AAP
MBOT icon

Arax Advisory Partners’s Microbot Medical MBOT Stock Holding History

Arax Advisory Partners’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.67K Buy
1,107
+419
+61% +$936 ﹤0.01% 3024
2025
Q4 		$1.38K Buy
688
+382
+125% +$905 ﹤0.01% 3396
2025
Q3 		$934 Buy
+306
New +$954 ﹤0.01% 3270

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Arax Advisory Partners's MBOT Position: Q1 2026 in Review

Arax Advisory Partners increased its Microbot Medical (MBOT) stake by 61% in Q1 2026, buying an estimated $936 and bringing the position to 1,107 shares worth $2.67K. The position accounts for ﹤0.01% of the portfolio, ranked #3024.

Arax Advisory Partners first reported a position in MBOT in Q3 2025 and has held it in 3 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Arax Advisory Partners held 1,107 shares of Microbot Medical worth $2.67K as of Q1 2026.
  • Arax Advisory Partners bought 419 Microbot Medical shares in Q1 2026, an estimated $936.
  • Microbot Medical made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #3024 holding.
  • Arax Advisory Partners first reported a position in Microbot Medical in Q3 2025 and has held it in 3 quarters since.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.